NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/06/2026
Voltar para busca
Dado oficial do USPTO
QALVORA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
30/06/2026
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
15/01/2025
Data de registro
30/06/2026
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
09/10/2025
Primeiro uso no comércio
10/10/2025
Código do desenho
4
Tipo de titular
01
Localização do titular
Shenzhen, CN
Examinador
GULIANO, ROBERT N
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
W. Y. (pessoa física)
Representantes
Marek Krizka SPARRING LEGAL LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Medical devices and apparatusmedical guidewires and parts and fittings therefor; Medical devices and apparatusmesh graft made primarily of artificial materials for pelvic floor reconstruction; Medical devices and apparatusultrasound imaging apparatusscanners and needle guidesparts and fittings therefor; Medical devices and apparatusvacuum assisted breast biopsy system and parts and fittings therefor; Medical devices for closing wounds; Medical devices for monitoring blood oxygen saturationblood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signsblood properties and respiratory events; Medical devices for moxibustion therapy; Medical devices for nonsurgical cosmetic treatments; Medical devices for obtaining body fluid samples; Medical devices for placing and securing catheters; Medical devices for treating congestive heart failure; Medical devices for treating sleep disorders; Medical devices for treating vascular bifurcations; Medical devices for use in cannulation or to stem the flow of traumatic bleedingtourniquets; Medical devices to treat intravascular sites; Medical devices used in colostomy procedures to collect waste materials; Medical devicesdevices for measuring wounds; Medical deviceshand-held motorizedvibrating devices used near injection sites for reducing pain during hypodermic needle injections; Medical devicesminimally invasive devices for abdominal aortic aneurysms repair; Medical devicesminimally invasive neurovascular devices for the treatment of neurological conditions; Medical devicesmyocardial ischemia scanning devices; Medical devicessurgical devices that facilitate the identificationseparation or ablation of biologic tissues; Medical apparatusbi-level positive airway pressure (BPAP) devices; Medical apparatuscontinuous positive airway pressure (CPAP) devices; Medical apparatuselectric heating devices for curative treatment; Medical apparatusinfusion and injection devices for administering drugs; Medical apparatusnon- or low-compression devices for holding thermal packs to the breasts; Medical apparatustherapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; Medical apparatustick removal devices; Medical apparatustiming devices for uterine contractions; Medical apparatusvariable positive airway pressure devices (VPAP); Medical cutting devices; Medical hearing instruments and parts of such devices; Medical lancing devices; Medical testing devices for measuring hearing loss in patientsaudiometers; Attachments for medical injection devices to aid in controlling the depth of the injections; Attachments for medical injection devices to aid in holding injection needles perpendicular to the skin; Attachments for medical injection devices to aid in stabilizing flow during injection of pharmaceuticals; Blood pressure and diabetic diagnostic medical devices; Clothing extension support devices for use during pregnancy for medical purposes; Coatings sold as an integral component of medical stents and other implantable medical devices; Disposable medical devices for treating constipation; Light emitting diode (LED) devices for energy-efficient replacement of standard tungsten-filament lighting incorporated into hand-held medical instruments; Mountable medical devices that hold pre-folded military tourniquets for rapid acquisition and deployment thereof; Non-invasive medical devices for use in treating urinary incontinence; Portable medical devices used for breathing exercisesportable devices used for endogenous breathing exercises and for respiratory muscle training; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Saliva collection devices for medical purposes; Surgical and medical implant devices composed of artificial materialsvertebral staple-shaped implants; Telemetry devices for medical applications
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/06/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/06/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/05/2026
GNRT
NON-FINAL ACTION E-MAILED
21/05/2026
CNRT
SU - NON-FINAL ACTION - WRITTEN
21/05/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/05/2026
ALIE
ASSIGNED TO LIE
21/05/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/05/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2026
GNRT
NON-FINAL ACTION E-MAILED
11/05/2026
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/05/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
24/04/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/04/2026
IUAF
USE AMENDMENT FILED
30/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
30/11/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2025
GNRT
NON-FINAL ACTION E-MAILED
02/07/2025
CNRT
NON-FINAL ACTION WRITTEN
02/07/2025
DOCK
ASSIGNED TO EXAMINER
24/06/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/06/2025
NWAP
NEW APPLICATION ENTERED
15/01/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QALVORA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.